Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy
2022 · Biomedicine & Pharmacotherapy · 61 citations
https://doi.org/10.1016/j.biopha.2022.113947
H
Hongwei Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
658
Citations
15
h-index
20
i10-index
Hongwei Wu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Renal and related cancers & Chronic Kidney Disease and Diabetes & Birth, Development, and Health. The author has an h-index of 15, co-authored 56 publications.
ORCID: 0000-0002-1775-5042Papers by this author
worksSGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
2022 · Journal of Translational Medicine · 50 citations
https://doi.org/10.1186/s12967-022-03629-8
Integrating spatial transcriptomics with single-cell transcriptomics reveals a spatiotemporal gene landscape of the human developing kidney
2022 · Cell & Bioscience · 15 citations
https://doi.org/10.1186/s13578-022-00801-x
Gene-regulatory network analysis of ankylosing spondylitis with a single-cell chromatin accessible assay
2020 · Scientific Reports · 11 citations
https://doi.org/10.1038/s41598-020-76574-5
Renal and cardiac effects of the PDE9 inhibitor BAY 73–6691 in 5/6 nephrectomized rats
2024 · Pflügers Archiv - European Journal of Physiology · 1 citations
https://doi.org/10.1007/s00424-024-02915-2
C3G improves lipid droplet accumulation in the proximal tubules of high-fat diet-induced ORG mice
2024 · Pharmacological Research · 1 citations
https://doi.org/10.1016/j.phrs.2024.107550
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat